XML 26 R26.htm IDEA: XBRL DOCUMENT

Note 10 - Operations and Industry Segments (Tables)

9 Months Ended

Jun. 29, 2013

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Three Months Ended						Nine Months Ended
	June 29,			June 30,			June 29,			June 30,
	2013			2012			2013			2012
Net sales:
Medical	$	13,427,180		$	11,618,522		$	36,319,007		$	34,792,619
Custom products		5,194,032			5,318,607			20,585,620			23,571,938
Total	$	18,621,212		$	16,937,129		$	56,904,627		$	58,364,557

Operating profit:
Medical	$	1,816,406		$	1,101,343		$	4,129,152		$	3,809,075
Custom products		179,703			238,157			2,074,631			2,200,179
Total		1,996,109			1,339,500			6,203,783			6,009,254

Corporate expense		(181,888	)		(193,599	)		(499,459	)		(460,371	)
Other expense		(2,337	)		(22,447	)		(39,994	)		(47,463	)
Income before income taxes	$	1,811,884		$	1,123,454		$	5,664,330		$	5,501,420

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details